Piloting the Queen Mary: The Unique Challenges of Cardiovascular Outcome Studies

Sponsored by: Worldwide Clinical Trials

Dr. Michael Murphy, M.D., Ph.D., Chief Medical and Scientific Officer
Karen Hill, VP Global Operations, Cardiovascular
Toni Bransford, Senior Medical Director, Medical & Scientific Affairs
Chris Standley, VP Trial Technologies

Thursday - September 29, 2016 / 11:00 am EDT
Free Event

Cardiovascular outcome studies can be a bit like piloting the Queen Mary – multiple compartments, complex interrelated activities, difficult to launch and bring into port.

To commemorate World Heart Day on September 29th, Worldwide Clinical Trial experts will highlight common challenges and key success factors, as well as design and operational conventions in cardiovascular outcome trials.

Key topics to be discussed:

• The need for scalable operational and technological infrastructure
• Relationship management across diverse stakeholders
• Novel developments in trial methodology
• Regional differences in standards of care

About the Sponsors

Worldwide Clinical Trials employs more than 1,400 professionals around the world. One of the world’s leading, full-service contract research organizations (CROs), Worldwide partners with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies.

For more information please visit www.worldwide.com/cardiovascular.

Comments are closed.